Phase 2 Study Evaluating Ganetespib in Metastatic Breast Cancer

jenrio

Anyone interested?   One is for HR- (including triple negative) and another is for HR+  

http://clinicaltrials.gov/ct2/show/NCT01677455?term=ganetespib+breast+cancer&rank=1

http://clinicaltrials.gov/ct2/show/NCT01560416?term=ganetespib+breast+cancer&rank=3

The reason I mention this drug, is that HSP90 is a big target on a lot of different cancers.    There are other drugs targetting HSP90.   I'm just looking through them.